These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27729477)

  • 1. Blood-Brain Barrier Disruption and Neurovascular Unit Dysfunction in Diabetic Mice: Protection with the Mitochondrial Carbonic Anhydrase Inhibitor Topiramate.
    Salameh TS; Shah GN; Price TO; Hayden MR; Banks WA
    J Pharmacol Exp Ther; 2016 Dec; 359(3):452-459. PubMed ID: 27729477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.
    Price TO; Eranki V; Banks WA; Ercal N; Shah GN
    Endocrinology; 2012 Jan; 153(1):362-72. PubMed ID: 22109883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: Implications for cerebral microvascular disease in diabetes.
    Shah GN; Morofuji Y; Banks WA; Price TO
    Biochem Biophys Res Commun; 2013 Oct; 440(2):354-8. PubMed ID: 24076121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the hippocampal and hypothalamic blood-brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate.
    Salameh TS; Mortell WG; Logsdon AF; Butterfield DA; Banks WA
    Fluids Barriers CNS; 2019 Jan; 16(1):1. PubMed ID: 30616618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Blood-Brain Barrier Interface in Diabetes Mellitus: Dysfunctions, Mechanisms and Approaches to Treatment.
    Banks WA
    Curr Pharm Des; 2020; 26(13):1438-1447. PubMed ID: 32209037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis.
    Shah GN; Price TO; Banks WA; Morofuji Y; Kovac A; Ercal N; Sorenson CM; Shin ES; Sheibani N
    J Pharmacol Exp Ther; 2013 Mar; 344(3):637-45. PubMed ID: 23249625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10?
    Sajja RK; Prasad S; Tang S; Kaisar MA; Cucullo L
    Neurosci Lett; 2017 Jul; 653():152-158. PubMed ID: 28572033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
    Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M
    Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models.
    Rom S; Zuluaga-Ramirez V; Gajghate S; Seliga A; Winfield M; Heldt NA; Kolpakov MA; Bashkirova YV; Sabri AK; Persidsky Y
    Mol Neurobiol; 2019 Mar; 56(3):1883-1896. PubMed ID: 29974394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
    Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
    Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetes exacerbates blood-brain barrier alterations during experimental epileptic seizures in an animal model.
    Yorulmaz H; Kaptan E; Seker FB; Oztas B
    Cell Biochem Funct; 2015 Jul; 33(5):285-92. PubMed ID: 26011758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effect of Topiramate on Hyperglycemia-Induced Cerebral Oxidative Stress, Pericyte Loss and Learning Behavior in Diabetic Mice.
    Price TO; Farr SA; Niehoff ML; Ercal N; Morley JE; Shah GN
    Int Libr Diabetes Metab; 2015 Mar; 1(1):6-12. PubMed ID: 26120599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintaining blood-brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation.
    Al Ahmad A; Gassmann M; Ogunshola OO
    J Cell Physiol; 2009 Mar; 218(3):612-22. PubMed ID: 19016245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate Protects Pericytes from Glucotoxicity: Role for Mitochondrial CA VA in Cerebromicrovascular Disease in Diabetes.
    Patrick P; Price TO; Diogo AL; Sheibani N; Banks WA; Shah GN
    J Endocrinol Diabetes; 2015; 2(2):. PubMed ID: 26167540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin receptor deficiency induces early, transient and hyperglycaemia-independent blood-brain barrier dysfunction.
    Corem N; Anzi S; Gelb S; Ben-Zvi A
    Sci Rep; 2019 Feb; 9(1):2884. PubMed ID: 30814586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
    Awad AS
    Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage.
    Lin L; Chen Z; Huang C; Wu Y; Huang L; Wang L; Ke S; Liu L
    Mol Neurobiol; 2023 Feb; 60(2):672-686. PubMed ID: 36357613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neurovascular blood-brain barrier in vitro model.
    Zehendner CM; White R; Hedrich J; Luhmann HJ
    Methods Mol Biol; 2014; 1135():403-13. PubMed ID: 24510882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of oxidative stress in hypoxia-induced blood-brain barrier breakdown.
    Al Ahmad A; Gassmann M; Ogunshola OO
    Microvasc Res; 2012 Sep; 84(2):222-5. PubMed ID: 22668821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurovascular coupling in cognitive impairment associated with diabetes mellitus.
    Mogi M; Horiuchi M
    Circ J; 2011; 75(5):1042-8. PubMed ID: 21441696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.